EP0000977B1 - Aggregated polyelectrolytes, their preparation and uses in the fractionation of blood and other proteinaceous substances - Google Patents
Aggregated polyelectrolytes, their preparation and uses in the fractionation of blood and other proteinaceous substances Download PDFInfo
- Publication number
- EP0000977B1 EP0000977B1 EP78300175A EP78300175A EP0000977B1 EP 0000977 B1 EP0000977 B1 EP 0000977B1 EP 78300175 A EP78300175 A EP 78300175A EP 78300175 A EP78300175 A EP 78300175A EP 0000977 B1 EP0000977 B1 EP 0000977B1
- Authority
- EP
- European Patent Office
- Prior art keywords
- polymer
- amine
- aggregated
- imide
- polyelectrolyte
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 229920000867 polyelectrolyte Polymers 0.000 title claims description 42
- 238000005194 fractionation Methods 0.000 title claims description 10
- 239000000126 substance Substances 0.000 title claims description 6
- 210000004369 blood Anatomy 0.000 title claims description 4
- 239000008280 blood Substances 0.000 title claims description 4
- 238000002360 preparation method Methods 0.000 title description 10
- 229920000642 polymer Polymers 0.000 claims description 91
- 238000000034 method Methods 0.000 claims description 51
- 150000001412 amines Chemical class 0.000 claims description 34
- 229920001577 copolymer Polymers 0.000 claims description 30
- 239000000178 monomer Substances 0.000 claims description 29
- 238000004220 aggregation Methods 0.000 claims description 28
- 230000002776 aggregation Effects 0.000 claims description 28
- 150000008064 anhydrides Chemical class 0.000 claims description 22
- 239000000203 mixture Substances 0.000 claims description 19
- 239000002253 acid Substances 0.000 claims description 17
- 239000002245 particle Substances 0.000 claims description 17
- 102000004169 proteins and genes Human genes 0.000 claims description 16
- 108090000623 proteins and genes Proteins 0.000 claims description 16
- 125000004432 carbon atom Chemical group C* 0.000 claims description 15
- 238000001179 sorption measurement Methods 0.000 claims description 13
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 claims description 11
- 238000004132 cross linking Methods 0.000 claims description 11
- 238000010438 heat treatment Methods 0.000 claims description 11
- 239000008096 xylene Substances 0.000 claims description 11
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 claims description 10
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 claims description 8
- 239000005977 Ethylene Substances 0.000 claims description 8
- FPYJFEHAWHCUMM-UHFFFAOYSA-N maleic anhydride Chemical compound O=C1OC(=O)C=C1 FPYJFEHAWHCUMM-UHFFFAOYSA-N 0.000 claims description 8
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 claims description 7
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical class C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 claims description 7
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Chemical class C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 claims description 7
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 claims description 7
- 239000011976 maleic acid Substances 0.000 claims description 7
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 claims description 7
- 150000007513 acids Chemical class 0.000 claims description 6
- 238000009835 boiling Methods 0.000 claims description 6
- 238000006467 substitution reaction Methods 0.000 claims description 6
- YNQLUTRBYVCPMQ-UHFFFAOYSA-N Ethylbenzene Chemical compound CCC1=CC=CC=C1 YNQLUTRBYVCPMQ-UHFFFAOYSA-N 0.000 claims description 4
- VQTUBCCKSQIDNK-UHFFFAOYSA-N Isobutene Chemical group CC(C)=C VQTUBCCKSQIDNK-UHFFFAOYSA-N 0.000 claims description 4
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical class C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 claims description 4
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical class C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 claims description 4
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical class C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 claims description 4
- MVPPADPHJFYWMZ-UHFFFAOYSA-N chlorobenzene Chemical compound ClC1=CC=CC=C1 MVPPADPHJFYWMZ-UHFFFAOYSA-N 0.000 claims description 4
- RWGFKTVRMDUZSP-UHFFFAOYSA-N cumene Chemical compound CC(C)C1=CC=CC=C1 RWGFKTVRMDUZSP-UHFFFAOYSA-N 0.000 claims description 4
- 239000003960 organic solvent Substances 0.000 claims description 4
- 239000003791 organic solvent mixture Substances 0.000 claims description 4
- OCJBOOLMMGQPQU-UHFFFAOYSA-N 1,4-dichlorobenzene Chemical compound ClC1=CC=C(Cl)C=C1 OCJBOOLMMGQPQU-UHFFFAOYSA-N 0.000 claims description 3
- 229940117389 dichlorobenzene Drugs 0.000 claims description 3
- BSKHPKMHTQYZBB-UHFFFAOYSA-N 2-methylpyridine Chemical class CC1=CC=CC=N1 BSKHPKMHTQYZBB-UHFFFAOYSA-N 0.000 claims description 2
- 239000012442 inert solvent Substances 0.000 claims description 2
- 239000007788 liquid Substances 0.000 claims description 2
- 150000002689 maleic acids Chemical class 0.000 claims description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N pyridine Substances C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims description 2
- 239000011877 solvent mixture Substances 0.000 claims description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims 1
- 150000003222 pyridines Chemical class 0.000 claims 1
- 239000000047 product Substances 0.000 description 47
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 38
- 238000010992 reflux Methods 0.000 description 30
- 239000002002 slurry Substances 0.000 description 30
- 238000006243 chemical reaction Methods 0.000 description 24
- 239000002904 solvent Substances 0.000 description 20
- YXVIXWDTSCFZHY-UHFFFAOYSA-N 3-imino-N-methyl-N-propylpropan-1-amine Chemical compound CN(CCC=N)CCC YXVIXWDTSCFZHY-UHFFFAOYSA-N 0.000 description 19
- 230000008569 process Effects 0.000 description 17
- KFYRJJBUHYILSO-YFKPBYRVSA-N (2s)-2-amino-3-dimethylarsanylsulfanyl-3-methylbutanoic acid Chemical compound C[As](C)SC(C)(C)[C@@H](N)C(O)=O KFYRJJBUHYILSO-YFKPBYRVSA-N 0.000 description 16
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 12
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 11
- 238000001914 filtration Methods 0.000 description 11
- 239000000463 material Substances 0.000 description 10
- -1 1-do-decene Chemical compound 0.000 description 9
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 9
- 239000011347 resin Substances 0.000 description 9
- 229920005989 resin Polymers 0.000 description 9
- 238000010533 azeotropic distillation Methods 0.000 description 8
- 150000003949 imides Chemical class 0.000 description 8
- 238000003756 stirring Methods 0.000 description 8
- 230000008961 swelling Effects 0.000 description 8
- 230000015572 biosynthetic process Effects 0.000 description 7
- 238000010626 work up procedure Methods 0.000 description 7
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 6
- NAQMVNRVTILPCV-UHFFFAOYSA-N hexane-1,6-diamine Chemical compound NCCCCCCN NAQMVNRVTILPCV-UHFFFAOYSA-N 0.000 description 6
- 239000011780 sodium chloride Substances 0.000 description 6
- 239000003054 catalyst Substances 0.000 description 5
- 238000001035 drying Methods 0.000 description 5
- 125000000524 functional group Chemical group 0.000 description 5
- 238000000227 grinding Methods 0.000 description 5
- 125000005462 imide group Chemical group 0.000 description 5
- 210000002381 plasma Anatomy 0.000 description 5
- 150000003839 salts Chemical group 0.000 description 5
- 102000009027 Albumins Human genes 0.000 description 4
- 108010088751 Albumins Proteins 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 238000000498 ball milling Methods 0.000 description 4
- IUNMPGNGSSIWFP-UHFFFAOYSA-N dimethylaminopropylamine Chemical compound CN(C)CCCN IUNMPGNGSSIWFP-UHFFFAOYSA-N 0.000 description 4
- 238000000605 extraction Methods 0.000 description 4
- 239000012467 final product Substances 0.000 description 4
- QCQCHGYLTSGIGX-GHXANHINSA-N 4-[[(3ar,5ar,5br,7ar,9s,11ar,11br,13as)-5a,5b,8,8,11a-pentamethyl-3a-[(5-methylpyridine-3-carbonyl)amino]-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3h-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid Chemical group N([C@@]12CC[C@@]3(C)[C@]4(C)CC[C@H]5C(C)(C)[C@@H](OC(=O)CC(C)(C)C(O)=O)CC[C@]5(C)[C@H]4CC[C@@H]3C1=C(C(C2)=O)C(C)C)C(=O)C1=CN=CC(C)=C1 QCQCHGYLTSGIGX-GHXANHINSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 125000001931 aliphatic group Chemical group 0.000 description 3
- 125000003368 amide group Chemical group 0.000 description 3
- 150000001244 carboxylic acid anhydrides Chemical class 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- 238000006482 condensation reaction Methods 0.000 description 3
- 239000002270 dispersing agent Substances 0.000 description 3
- 239000006185 dispersion Substances 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- UDGSVBYJWHOHNN-UHFFFAOYSA-N n',n'-diethylethane-1,2-diamine Chemical compound CCN(CC)CCN UDGSVBYJWHOHNN-UHFFFAOYSA-N 0.000 description 3
- 238000006116 polymerization reaction Methods 0.000 description 3
- 239000000376 reactant Substances 0.000 description 3
- 239000011541 reaction mixture Substances 0.000 description 3
- 125000001424 substituent group Chemical group 0.000 description 3
- 229920002554 vinyl polymer Polymers 0.000 description 3
- MYRTYDVEIRVNKP-UHFFFAOYSA-N 1,2-Divinylbenzene Chemical compound C=CC1=CC=CC=C1C=C MYRTYDVEIRVNKP-UHFFFAOYSA-N 0.000 description 2
- AFFLGGQVNFXPEV-UHFFFAOYSA-N 1-decene Chemical compound CCCCCCCCC=C AFFLGGQVNFXPEV-UHFFFAOYSA-N 0.000 description 2
- WAKUKXKZEXFXJP-UHFFFAOYSA-N 1-ethylpiperidin-3-amine Chemical compound CCN1CCCC(N)C1 WAKUKXKZEXFXJP-UHFFFAOYSA-N 0.000 description 2
- LIKMAJRDDDTEIG-UHFFFAOYSA-N 1-hexene Chemical compound CCCCC=C LIKMAJRDDDTEIG-UHFFFAOYSA-N 0.000 description 2
- KWKAKUADMBZCLK-UHFFFAOYSA-N 1-octene Chemical compound CCCCCCC=C KWKAKUADMBZCLK-UHFFFAOYSA-N 0.000 description 2
- ICSNLGPSRYBMBD-UHFFFAOYSA-N 2-aminopyridine Chemical compound NC1=CC=CC=N1 ICSNLGPSRYBMBD-UHFFFAOYSA-N 0.000 description 2
- WWUVJRULCWHUSA-UHFFFAOYSA-N 2-methyl-1-pentene Chemical compound CCCC(C)=C WWUVJRULCWHUSA-UHFFFAOYSA-N 0.000 description 2
- CJNRGSHEMCMUOE-UHFFFAOYSA-N 2-piperidin-1-ylethanamine Chemical compound NCCN1CCCCC1 CJNRGSHEMCMUOE-UHFFFAOYSA-N 0.000 description 2
- XPQIPUZPSLAZDV-UHFFFAOYSA-N 2-pyridylethylamine Chemical compound NCCC1=CC=CC=N1 XPQIPUZPSLAZDV-UHFFFAOYSA-N 0.000 description 2
- UIKUBYKUYUSRSM-UHFFFAOYSA-N 3-morpholinopropylamine Chemical compound NCCCN1CCOCC1 UIKUBYKUYUSRSM-UHFFFAOYSA-N 0.000 description 2
- 239000004971 Cross linker Substances 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 125000002723 alicyclic group Chemical group 0.000 description 2
- 125000003277 amino group Chemical group 0.000 description 2
- 125000003118 aryl group Chemical group 0.000 description 2
- IAQRGUVFOMOMEM-UHFFFAOYSA-N but-2-ene Chemical compound CC=CC IAQRGUVFOMOMEM-UHFFFAOYSA-N 0.000 description 2
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 2
- 150000001735 carboxylic acids Chemical class 0.000 description 2
- 125000002091 cationic group Chemical group 0.000 description 2
- 239000007795 chemical reaction product Substances 0.000 description 2
- 238000005345 coagulation Methods 0.000 description 2
- 230000015271 coagulation Effects 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 125000004122 cyclic group Chemical group 0.000 description 2
- ZQMIGQNCOMNODD-UHFFFAOYSA-N diacetyl peroxide Chemical compound CC(=O)OOC(C)=O ZQMIGQNCOMNODD-UHFFFAOYSA-N 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- 238000004821 distillation Methods 0.000 description 2
- VXNZUUAINFGPBY-UHFFFAOYSA-N ethyl ethylene Natural products CCC=C VXNZUUAINFGPBY-UHFFFAOYSA-N 0.000 description 2
- 239000012065 filter cake Substances 0.000 description 2
- 230000004927 fusion Effects 0.000 description 2
- 230000005484 gravity Effects 0.000 description 2
- 125000000623 heterocyclic group Chemical group 0.000 description 2
- 239000012452 mother liquor Substances 0.000 description 2
- RWIVICVCHVMHMU-UHFFFAOYSA-N n-aminoethylmorpholine Chemical compound NCCN1CCOCC1 RWIVICVCHVMHMU-UHFFFAOYSA-N 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- CCCMONHAUSKTEQ-UHFFFAOYSA-N octadec-1-ene Chemical compound CCCCCCCCCCCCCCCCC=C CCCMONHAUSKTEQ-UHFFFAOYSA-N 0.000 description 2
- 150000002978 peroxides Chemical class 0.000 description 2
- 229920000098 polyolefin Polymers 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 239000012066 reaction slurry Substances 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- OKIRBHVFJGXOIS-UHFFFAOYSA-N 1,2-di(propan-2-yl)benzene Chemical compound CC(C)C1=CC=CC=C1C(C)C OKIRBHVFJGXOIS-UHFFFAOYSA-N 0.000 description 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- HJORCZCMNWLHMB-UHFFFAOYSA-N 1-(3-aminopropyl)pyrrolidin-2-one Chemical compound NCCCN1CCCC1=O HJORCZCMNWLHMB-UHFFFAOYSA-N 0.000 description 1
- OSSNTDFYBPYIEC-UHFFFAOYSA-N 1-ethenylimidazole Chemical compound C=CN1C=CN=C1 OSSNTDFYBPYIEC-UHFFFAOYSA-N 0.000 description 1
- CAPCBAYULRXQAN-UHFFFAOYSA-N 1-n,1-n-diethylpentane-1,4-diamine Chemical compound CCN(CC)CCCC(C)N CAPCBAYULRXQAN-UHFFFAOYSA-N 0.000 description 1
- SEYURSMOEWBZSA-UHFFFAOYSA-N 2-(1-ethylpyrrolidin-2-yl)ethanamine Chemical compound CCN1CCCC1CCN SEYURSMOEWBZSA-UHFFFAOYSA-N 0.000 description 1
- LBFFKXDGKVMZQS-UHFFFAOYSA-N 2-(3-aminopropylamino)ethane-1,1-diol Chemical compound NCCCNCC(O)O LBFFKXDGKVMZQS-UHFFFAOYSA-N 0.000 description 1
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 1
- PXJBCMWIAPDWAU-UHFFFAOYSA-N 2-piperidin-4-ylethanamine Chemical compound NCCC1CCNCC1 PXJBCMWIAPDWAU-UHFFFAOYSA-N 0.000 description 1
- VPBWZBGZWHDNKL-UHFFFAOYSA-N 3-pyrrolidin-1-ylpropan-1-amine Chemical compound NCCCN1CCCC1 VPBWZBGZWHDNKL-UHFFFAOYSA-N 0.000 description 1
- ORLGLBZRQYOWNA-UHFFFAOYSA-N 4-methylpyridin-2-amine Chemical compound CC1=CC=NC(N)=C1 ORLGLBZRQYOWNA-UHFFFAOYSA-N 0.000 description 1
- QUXLCYFNVNNRBE-UHFFFAOYSA-N 6-methylpyridin-2-amine Chemical compound CC1=CC=CC(N)=N1 QUXLCYFNVNNRBE-UHFFFAOYSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 239000004342 Benzoyl peroxide Substances 0.000 description 1
- OMPJBNCRMGITSC-UHFFFAOYSA-N Benzoylperoxide Chemical compound C=1C=CC=CC=1C(=O)OOC(=O)C1=CC=CC=C1 OMPJBNCRMGITSC-UHFFFAOYSA-N 0.000 description 1
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 1
- 102000008100 Human Serum Albumin Human genes 0.000 description 1
- 108091006905 Human Serum Albumin Proteins 0.000 description 1
- YIVJZNGAASQVEM-UHFFFAOYSA-N Lauroyl peroxide Chemical compound CCCCCCCCCCCC(=O)OOC(=O)CCCCCCCCCCC YIVJZNGAASQVEM-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- XTXRWKRVRITETP-UHFFFAOYSA-N Vinyl acetate Chemical compound CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 description 1
- BZHJMEDXRYGGRV-UHFFFAOYSA-N Vinyl chloride Chemical compound ClC=C BZHJMEDXRYGGRV-UHFFFAOYSA-N 0.000 description 1
- 108010067390 Viral Proteins Proteins 0.000 description 1
- MZVQCMJNVPIDEA-UHFFFAOYSA-N [CH2]CN(CC)CC Chemical class [CH2]CN(CC)CC MZVQCMJNVPIDEA-UHFFFAOYSA-N 0.000 description 1
- 150000008065 acid anhydrides Chemical class 0.000 description 1
- 150000003926 acrylamides Chemical class 0.000 description 1
- 150000001252 acrylic acid derivatives Chemical class 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 125000002015 acyclic group Chemical group 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000001338 aliphatic hydrocarbons Chemical class 0.000 description 1
- 150000001336 alkenes Chemical group 0.000 description 1
- 125000005250 alkyl acrylate group Chemical group 0.000 description 1
- 150000003973 alkyl amines Chemical class 0.000 description 1
- XYLMUPLGERFSHI-UHFFFAOYSA-N alpha-Methylstyrene Chemical compound CC(=C)C1=CC=CC=C1 XYLMUPLGERFSHI-UHFFFAOYSA-N 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 150000001414 amino alcohols Chemical class 0.000 description 1
- IMUDHTPIFIBORV-UHFFFAOYSA-N aminoethylpiperazine Chemical compound NCCN1CCNCC1 IMUDHTPIFIBORV-UHFFFAOYSA-N 0.000 description 1
- 229950011175 aminopicoline Drugs 0.000 description 1
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 1
- 150000001555 benzenes Chemical class 0.000 description 1
- 235000019400 benzoyl peroxide Nutrition 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 238000010261 blood fractionation Methods 0.000 description 1
- IWTBWSGPDGPTIB-UHFFFAOYSA-N butanoyl butaneperoxoate Chemical compound CCCC(=O)OOC(=O)CCC IWTBWSGPDGPTIB-UHFFFAOYSA-N 0.000 description 1
- 125000002843 carboxylic acid group Chemical group 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000007334 copolymerization reaction Methods 0.000 description 1
- 229920006037 cross link polymer Polymers 0.000 description 1
- 239000011243 crosslinked material Substances 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 230000001627 detrimental effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- LSXWFXONGKSEMY-UHFFFAOYSA-N di-tert-butyl peroxide Chemical compound CC(C)(C)OOC(C)(C)C LSXWFXONGKSEMY-UHFFFAOYSA-N 0.000 description 1
- XNMQEEKYCVKGBD-UHFFFAOYSA-N dimethylacetylene Natural products CC#CC XNMQEEKYCVKGBD-UHFFFAOYSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 125000004185 ester group Chemical group 0.000 description 1
- YYXLGGIKSIZHSF-UHFFFAOYSA-N ethene;furan-2,5-dione Chemical compound C=C.O=C1OC(=O)C=C1 YYXLGGIKSIZHSF-UHFFFAOYSA-N 0.000 description 1
- GFJVXXWOPWLRNU-UHFFFAOYSA-N ethenyl formate Chemical compound C=COC=O GFJVXXWOPWLRNU-UHFFFAOYSA-N 0.000 description 1
- 125000005670 ethenylalkyl group Chemical group 0.000 description 1
- 229940052303 ethers for general anesthesia Drugs 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000011152 fibreglass Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 150000003840 hydrochlorides Chemical class 0.000 description 1
- 125000004356 hydroxy functional group Chemical group O* 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 150000003951 lactams Chemical group 0.000 description 1
- 150000002596 lactones Chemical class 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 150000002734 metacrylic acid derivatives Chemical class 0.000 description 1
- XJRBAMWJDBPFIM-UHFFFAOYSA-N methyl vinyl ether Chemical compound COC=C XJRBAMWJDBPFIM-UHFFFAOYSA-N 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- KYCGURZGBKFEQB-UHFFFAOYSA-N n',n'-dibutylpropane-1,3-diamine Chemical compound CCCCN(CCCC)CCCN KYCGURZGBKFEQB-UHFFFAOYSA-N 0.000 description 1
- QOHMWDJIBGVPIF-UHFFFAOYSA-N n',n'-diethylpropane-1,3-diamine Chemical compound CCN(CC)CCCN QOHMWDJIBGVPIF-UHFFFAOYSA-N 0.000 description 1
- DILRJUIACXKSQE-UHFFFAOYSA-N n',n'-dimethylethane-1,2-diamine Chemical compound CN(C)CCN DILRJUIACXKSQE-UHFFFAOYSA-N 0.000 description 1
- KMBPCQSCMCEPMU-UHFFFAOYSA-N n'-(3-aminopropyl)-n'-methylpropane-1,3-diamine Chemical compound NCCCN(C)CCCN KMBPCQSCMCEPMU-UHFFFAOYSA-N 0.000 description 1
- OCIDXARMXNJACB-UHFFFAOYSA-N n'-phenylethane-1,2-diamine Chemical compound NCCNC1=CC=CC=C1 OCIDXARMXNJACB-UHFFFAOYSA-N 0.000 description 1
- TVMXDCGIABBOFY-UHFFFAOYSA-N n-Octanol Natural products CCCCCCCC TVMXDCGIABBOFY-UHFFFAOYSA-N 0.000 description 1
- VDUIPQNXOQMTBF-UHFFFAOYSA-N n-ethylhydroxylamine Chemical compound CCNO VDUIPQNXOQMTBF-UHFFFAOYSA-N 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- HJWLCRVIBGQPNF-UHFFFAOYSA-N prop-2-enylbenzene Chemical compound C=CCC1=CC=CC=C1 HJWLCRVIBGQPNF-UHFFFAOYSA-N 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 1
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- TXQWFIVRZNOPCK-UHFFFAOYSA-N pyridin-4-ylmethanamine Chemical compound NCC1=CC=NC=C1 TXQWFIVRZNOPCK-UHFFFAOYSA-N 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 238000002407 reforming Methods 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 238000007873 sieving Methods 0.000 description 1
- 238000005549 size reduction Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 150000003613 toluenes Chemical class 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 238000003828 vacuum filtration Methods 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J3/00—Processes of treating or compounding macromolecular substances
- C08J3/12—Powdering or granulating
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F8/00—Chemical modification by after-treatment
- C08F8/30—Introducing nitrogen atoms or nitrogen-containing groups
- C08F8/32—Introducing nitrogen atoms or nitrogen-containing groups by reaction with amines
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L35/00—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a carboxyl radical, and containing at least one other carboxyl radical in the molecule, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2335/00—Characterised by the use of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a carboxyl radical, and containing at least one other carboxyl radical in the molecule, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Derivatives of such polymers
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/827—Proteins from mammals or birds
- Y10S530/829—Blood
- Y10S530/83—Plasma; serum
Definitions
- This invention relates to the production of improved polyelectrolytes which are useful in the fractionation of blood and other proteinaceous substances. More particularly, this invention relates to aggregated water-insoluble, cross-linked polyelectrolyte polymers having amine-imide functional groups.
- U.S. Patent 3,554,985 describes the preparation of water-insoluble, cross-linked polyelectrolyte polymers having diloweralkylaminoloweralkylimide functional groups, wherein loweralkyl has 1 to 5 carbon atoms.
- These polyelectrolytes have been found to be useful in the fractionation of blood plasma and serum as described in U.S. Patent 3,555,001 and for the separation of viruses from non-viral proteins as disclosed in U.S. Patents 3,655,509 and 3,846,543.
- polyelectrolyte polymers also are useful for the immunization of animals against viral diseases as seen from U.S. Patent 3,651,213 and for the purification of water by the removal of contaminating bacteria and viruses as set forth in U.S. Patent 3,398,092.
- the water-insoluble, cross-linked polyelectrolytes are further described as being copolymers of an (a) unsaturated monomer of 2 to 12 carbon atoms and (b) a monomer selected from the group consisting of (1) a mixture of an unsaturated polycarboxylic acid or anhydride and an unsaturated polycarboxylic acid amine-imide, and (2) an unsaturated polycarboxylic acid amine-imide.
- the starting copolymer comprises the reaction product of styrene and maleic anhydride cross-linked with divinyl benzene (Example 1, Column 16, which is subsequently converted to the amine-imide derivative by reaction with dimethylaminopropylamine (Example 2, column 16).
- a preformed polymer such as a copolymer of ethylene and maleic anhydride is cross-linked during the reaction with the dialkylaminoalkylamine by also employing in the reaction a predetermined amount of a difunctional compound such as ethylenediamine (column 12, lines 27-40).
- the method of the present invention is one of producing a water-insoluble, cross-linked polyelectrolyte containing amine-imide or amine-imide salt functional groups and having protein adsorption capacity from a polymer comprising a copolymer of (a) an unsaturated monomer having from 2 to 18 carbon atoms and (b) a monomer selected from unsaturated polycarboxylic acids or anhydrides having from 4 to 12 carbon atoms, characterised by heating the said polymer in an inert organic solvent or solvent mixture at a temperature ranging from about 115°C. to about 160°C.
- the said inert solvent or solvent mixture being an organic liquid medium having a boiling point of at least 115°C. at atmospheric pressure that substantially does not dissolve or react with the polymer under the conditons of the aggregation step, and thereafter cross-linking the polymer and substituting it with the major portion of the amine-imide or amine-imide salt functional groups.
- the invention also comprises a water-insoluble, cross-linked polyelectrolyte that is a copolymer of (a) unsaturated monomer having from 2 to 18 carbon atoms and (b) a monomer selected from' unsaturated polycarboxylic acid or anhydride having from 4 to 12 carbon atoms, and in which from 2 to 100% of the reactive sites in said copolymer are substituted with amine-imide or amine-imide salt functional groups, said polyelectrolyte being characterised by being aggregated such that the major proportion thereof has a particle size ranging from 50 to 200 microns prior to cross-linking and substitution with the major portion of said amine-imide or amine-imide salt functional groups.
- the invention also comprises the use of a polyelectrolyte according to the invention in the fractionation of blood or other proteinaceous substances.
- polyelectrolytes of the general type described hereinbefore are significantly and substantially improved by an aggregation process whereby the protein adsorption capacity not only is unimpaired but, surprisingly, also is improved in certain blood fractionation systems.
- the aggregation process comprises treatment of the preformed copolymer, prior to cross-linking and the addition of the functional amine-imide group, with refluxing xylene or other such inert organic solvents. This treatment is carried out at a temperature ranging from about 1 15°C. to about 160°C. but lower than the softening point of the polymer for at least about 15 minutes and until the polymer is substantially aggregated.
- the product obtained by this treatment is an aggregated polymer which filters rapidly and in which the filter cake breaks apart so easily that ball milling is no longer necessary in most instances. Drying of the filtered material also is faster with the aggregated polymer than with the unaggregated polymer.
- the protein adsorption capacity of the subsequently prepared cross-linked material containing the amine-imide functional group is substantially undiminished.
- the albumin adsorption capacity of the aggregated material has been found to be more than three times that of the unaggregated material.
- the properties of the aggregated polyelectrolyte in which grinding is unnecessary for obtaining suitable handling characteristics differ markedly from those of a ground, unaggregated polyelectrolyte. These differing products have non-equivalent particle structures. It has been found that the protein adsorption characteristics of these products involve both their chemical and physical properties.
- the desired aggregated polyelectrolyte is prepared with due consideration of difference in the molecular structure of the external shell and the internal core of the particles. When the particles are reduced by grinding, the shell-core relationships are changed.
- polyelectrolyte particles size reduction of polyelectrolyte particles is preferably avoided and (2) the desired structures for polyelectrolyte particles are achieved by synthesis sequences which develop the surface characteristics and basic core structure preferred for 'selective adsorption and elution of specific proteins.
- aggregation relates to the overall particle structure and its requirements for protein fractionation as well as providing important process advantages.
- the initial polymers which are aggregated in accordance with this invention include those disclosed in the aforementioned U.S. Patents 3,554,985 and 3,555,001, said patents being incorporated herein by reference.
- the initial polymer comprises a copolymer of (a) unsaturated monomer having from 2 to about 18 carbon atoms and (b) a monomer selected from the group consisting of unsaturated polycarboxylic acids and anhydrides having from 4 to about 12 carbon atoms.
- the aggregated polymer is cross-linked and substituted with an appropriate amine-imide group.
- Suitable amine-imide groups include not only those specifically described in U.S. Patents 3,554,985 and 3,555,001, but also cyclic amine-imide groups as defined hereinbelow.
- the desired aggregation process be carried out prior to the cross-linking and substitution with the major proportion of amine-imide groups. It has been found that when the cross-linking and/or the substitution with excessive amounts of the functional amine-imide group is carried out prior to the attempted aggregation process, the desired aggregation is not achieved and the advantages of the invention are not obtained. These results are surprising inasmuch as they are contrary to the expectation that the presence of the functional group would tend to make the polymer softer and thereby more readily susceptible to aggregation by simple particle fusion by the term "major proportion" is meant more than 50% of said groups.
- the importance of carrying out the aggregation process prior to cross-linking and/or the addition of the major portion of the functional group may be due in part to a bridging reaction to form acylic anhydride groups between carboxyl groups on the backbones of different polymer molecules on adjacent particle surfaces.
- This bridging differs from the usual anhydride formation by adjacent carboxyl groups on a backbone of a given polymer molecule.
- the anhydride copolymers normally contain up to 2% moisture, and a portion of this reacts with anhydride groups to form carboxylic acid groups while the remainder is assumed to be present as free water. The latter is rather easily lost on drying, while the former is released by reforming either cyclic or acyclic anhydride groups. This is a slower process; however, it occurs readily under conditions that favour aggregation, e.g., refluxing xylene.
- EMA-type polymers ethylene/maleic anhydride or acid
- the EMA-type polymers have been described previously in U.S. Patents 3,554,985 and 3,555,001 and are further illustrated by the general examples in the following section I:
- Co-monomers suitable for use with the above poly-carboxylic acid monomers include a-olefins, such as ethylene, 2-methyl-pentene-1, propylene, isobutylene, 1- or 2-butene, 1-hexene, 1-octene, 1- decene, 1-do-decene, 1-octadecene, and other vinyl monomers, such as styrene, a-methyl styrene, vinyltoluene, vinyl acetate, vinyl chloride, vinyl formate, vinyl alkyl ethers, e.g., methyl-vinyl-ether, alkyl acrylates, alkyl methacrylates, acrylamides and alkylacrylamides, or mixtures of these monomers. Reactivity of some functional groups in the copolymers resulting from some of these monomers permits formation of other useful functional groups in the formed copolymer, including hydroxy, lactone, amine and lactam groups.
- any of the said carboxylic acids or derivatives may be copolymerized with any of the other monomers described above, and any other monomer which forms a copolymer with unsaturated carboxylic acids or derivatives.
- these copolymers can be prepared by direct polymerization of the various monomers, frequently they are more easily prepared by an after-reaction modification of an existing copolymer. Copolymers are conveniently identified in terms of their monomeric constituents. The names so applied refer to the molecular structure and are not limited to the polymers prepared by the copolymerization of the specified monomers.
- EMA-type carboxylic acid or anhydride-olefin polymers especially maleic acid or anhydride-olefin polymers of the foregoing type are known, for example, from U.S. Patents 2,378,629; 2,396,785, 3,157,595; and 3,340,680.
- the copolymers are prepared by reacting ethylene or other unsaturated monomer, or mixtures thereof, with the acid anhydride in the presence of a peroxide catalyst in an aliphatic or aromatic hydrocarbon solvent for the monomers but nonsolvent for the interpolymer formed.
- Suitable solvents include benzene, toluene, xylene, chlorinated benzene and the like.
- the copolymer preferably contains substantially equimolar quantities of the olefin residue and the anhydride residue. Generally, it will have a degree of polymerization of about 8 to 100,000, preferably about 100 to 5,000, and a molecular weight of about 1,000 to 1,000,000, preferably about 10,000 to 500,000.
- the properties of the polymer are regulated by suitable choice of the catalyst and control of one or more of the variables such as ratio of reactants, temperature, and catalyst concentration or the addition of regulating chain transfer agents, such as diisopropyl benzene, propionic acid, alkyl aldehydes, and the like. Numerous of these polymers are commercially available.
- the aggregation of the foregoing EMA-type polymers and other such polymers as defined herein is carried out preferably by stirring the polymer as a suspension in refluxing or heated organic solvent which is inert to the polymer. This refluxing or heating is carried out at a temperature ranging from about 115°C. to about 160°C. but lower than the softening point of the polymer.
- a preferred solvent is xylene.
- Other solvents which can be used are, for example, ethylbenzene, mono- and dichlorobenzene and cumene. Solvents such as benzene and toluene having boiling points below about 115°C. are not practical for purposes of this invention.
- Heating of the polymer in the refluxing solvent for at least about 15 minutes is desired, and good results have been obtained by heating up to about one hour. Heating for prolonged periods of time substantially in excess of about one hour is unnecessary, but the aggregates remain stable in weak solvents even during such prolonged heat treatment up to 7 hours.
- the stronger solvents such as chlorobenzene and dichlorobenzene are less preferred solvents because of excessive coagulation that occurs on extended aggregation times.
- the aggregated polymer is cross-linked and substituted with the desired amine-imide groups in whatever sequence optimizes the properties being sought by tailoring the distribution of specific groups within the particles.
- These groups are essentially basic groups which can be aliphatic straight chain groups or can be alicyclic or aromatic groups.
- the aliphatic straight chain groups preferably are diloweralkylaminoloweralkylimide groups or loweralkyliminodi-(loweralkylimide) linkages wherein loweralkyl has 1 to 5 carbon atoms as described previously in U.S. Patents 3,554,985 and 3,555,001.
- Such products are further illustrated by the general examples in the following section II: //
- the initial copolymers of anhydrides and another monomer can be converted to amine or amine salts including quaternary salts by reaction of the carboxyls of their anhydride precursors where applicable with polyfunctional amines such as dimethylaminopropylamine at higher temperatures forming an imide linkage with vicinal carboxyls. Such pendant free amine groups can then be converted, if desired, to their simple or quaternary salts.
- Partial imides of a starting carboxyl or carboxylic acid anhydride containing polymer e.g., EMA, are produced by:
- Partial secondary or tertiary aminoloweralkylamides of the starting carboxyl or carboxylic acid anhydride-containing polymer are obtained by contacting the polymer with a limiting amount of the selected amine in suspension in a solvent such as benzene or hexane, resulting in formation of a partial amide-acid anhydride derivative or the polymer, or a corresponding amide- carboxylate derivative thereof.
- the number of amide groups is dependent upon the quantity of the amine used as compared with the quantity of polymer employed.
- Such amide-polymer products typically comprise 2-100% amide groups, with remaining carboxyl groups being present as acid or anhydride groups.
- Suitable blocking and unblocking of the amine moiety of the reactant employed in preparing amines or imides may be effected when required.
- Residual, non-modified polymer units may optionally be converted to neutral groups or units by attachment to the polymer molecule of compounds including alkylamines, amino-alcohols and alcohols.
- additional cationic character can be provided in the polymer through incorporation of monomers which impart a basic or cationic character such as C-vinyl pyridines, vinyl amine, the several amino-substituted vinyl benzenes (or toluenes and the like), amine-bearing acrylates (or methacrylates. and the like), vinyl imidazole and similar such monomers.
- monomers which impart a basic or cationic character such as C-vinyl pyridines, vinyl amine, the several amino-substituted vinyl benzenes (or toluenes and the like), amine-bearing acrylates (or methacrylates. and the like), vinyl imidazole and similar such monomers.
- the polymer product will have residual active or reactive groups which can be of various types, including mixtures, but these residual active or reactive groups or residual "reactive sites" in the polymer will in one way or another comprise a certain percentage which are of a basic nature, so as to impart the requisite basic nature to the polymer product.
- Especially preferred polymers subject to the previously referred to requirements are selected from the group consisting of ethylene/maleic acid or anhydride copolymers, styrene/maleic acid or anhydride copolmers, and isobutylene/maleic acid or anhydride copolymers.
- the preferred basic groups of the polycationic or polyampholytic polyelectrolyte (PE) employed are of an imide nature involving diloweralkylaminoloweralkylimide groupings, e.g., as produced by reacting a diloweralkylaminoloweralkylamine with the carboxyl groups of a pre-formed polymer. According to the invention, such groups are preferred for purposes of the invention.
- imide groups can be provided by cross-linking the polymer with a loweralkyliminobis(loweralkylamine) which in the process of cross-linking by reaction between the terminal amine groups of the cross-linker and carboxyl groups in the polymer chain is productive of imido groups at both ends of the cross-linking chain with formation of the desired loweralkyliminobis(loweralkylimide) linkages.
- a loweralkyliminobis(loweralkylamine) which in the process of cross-linking by reaction between the terminal amine groups of the cross-linker and carboxyl groups in the polymer chain is productive of imido groups at both ends of the cross-linking chain with formation of the desired loweralkyliminobis(loweralkylimide) linkages.
- Other groups such as diloweralkylaminoloweralkylimide groups, from which the desired imide groups can be obtained by heating at elevated temperatures, can also be present.
- diloweralkylaminoloweralkyl ester groups can be present, as well as other groups, so long as the imide groups of the prescribed type are also present in the polyelectrolyte molecule as well as the residual acid groups of the starting unsaturated acid or anhydride when the polyelectrolyte is a polyampholyte.
- the imide groups need not necessarily be present in the polyelectrolyte as such, but can be present in the form of their salts, as already indicated.
- Alicyclic or aromatic groups which can be substituted on the aggregated EMA-type polymers are for example, aminoloweralkyl-pyridine, piperidine, piperazine, picoline, pyrrolidine, morpholine and imidazole. These groups can be substituted on the aggregated polymer in a manner analogous to the aliphatic chain amines but by using, instead, cyclic amines such as, for example:
- Figure 1 of the drawings shows a photomicrograph of the aggregated polymer prepared in Example 3 at a magnification of 200 X. A similar polymer was prepared as in this example but without the aggregation process.
- Figure 2 of the drawings shows a photomicrograph of this unaggregated polymer prepared in Example 9 also at a magnification of 200 X. The striking differences in physical structure are readily apparent from these comparative photomicrographs.
- the polymer aggregates are a multiplicity of small individual particles held together in clusters without fusion.
- the major portion of the unaggregated polymer has a particle size ranging from about 0.1 microns to about 10 microns whereas the major portion of the aggregated polymer has a particle size ranging from about 50 to about 200 microns.
- a 5-liter reaction flask, equipped with reflux condenser, Dean-Stark water take-off, stirrer, reagent addition vessel, thermometer and nitrogen-purge attachments is charged with 193.05 g. ethylene/maleic anhydride copolymer (EMA) (1.5 moles, anhydride basis) and 2700 ml. xylene.
- EMA ethylene/maleic anhydride copolymer
- the charge is stirred at 200 r.p.m. with a 6.5 inch (0.165 metre) blade-type stirrer while it is heated to the reflux temperature.
- This reflux temperature will vary from 135 to 139°C. depending on the water content of the EMA and upon whether this water is azeotropically removed during the ensuing reflux period.
- the slurry was maintained at total reflux for 60 minutes under total reflux return at a temperature of 135°C.
- the reactor was cooled to 125°C. under nitrogen and a solution mixture of 10.89 g. MIBPA (0.075 mole) and 1.5 ml. water was added.
- the mixture was heated to reflux (134°C.) and maintained at reflux for 1 hour while continuously removing water azeotrop (final temperature was 137°C.).
- the reaction mixture was again lowered to 125°C. under nitrogen and a solution mixture of 153.3 g. DMAPA (1.5 moles) and 4.5 ml. water was added.
- the slurry was then heated to 133°C.
- the above slurry was filtered hot and the product cake was reslurried in 2700 ml. of a 3:1 mixture of xylene and ethanol, stirred at reflux temperature for one hour and then filtered hot. This was repeated a second time for a two hour period and a third time for a three hour refluxing period, in each case followed by hot filtration.
- the resulting extracted product cake was then reslurried in 2700 ml. hexane for 1 hour at room temperature and filtered. The hexane extraction was repeated a total of four times.
- the final product was airdried for 30 minutes and finally dried in a vacuum oven at 55°C.
- the final reaction slurry was filtered hot and the product cake reslurried at reflux in 3:1 xylene-alcohol three times, as above, followed by two 1-hour room temperature extractions with 2700 ml. acetone.
- the filtered product was converted to the hydrochloride by reslurrying in either 2700 ml. alcohol or acetone and gradually adding with stirring (over 10 min.) 112 ml. conc. (12N) hydrochloric acid and stirring at room temperature for two hours.
- the filtered product was subsequently washed (slurry with stirring) three consecutive times with 10 lites of water (deionized) for 2 hours each time and finally filtered.
- the filtered salt cake was reslurried four times in 2700 ml. acetone (1 hour each time) to remove the water, filtered, air dried for 30 minutes and vacuum oven dried at 55°C.
- the final dried product either as free amine or as salt, was screened without grinding with 95% of the product going through a 100 mesh screen before bottling for use.
- the aggregated diethylaminoethyl derivative was prepared using the identical procedure of Example 1 except that 174.32 g. DEAEA (1.5 mole) was substituted for the DMAPA in Example 1.
- the final product was obtained as the free amine form using the work-up procedure of Example 1 wherein the reaction product was consecutively extracted with three 3:1 xylene-alcohol extractions followed by four hexane extractions.
- the product was sieved unground through a 100 mesh screen to yield 229 g. of material finer than 100 mesh and 13.0 g. coarser than 100 mesh.
- This example utilized the same equipment, the same aggregation procedure and the same initial charge (EMA and xylene) as described in Example 1.
- the slurry temperature was lowered to 125°C. and 10.89 g. (0.075 moles) MIBPA was added.
- the slurry was stirred at 120-125°C for one hour without reflux.
- 7.66 g. (0.075 moles) DMAPA was added and the slurry was again stirred at 120-125°C. for one hour without reflux.
- the slurry was heated to reflux and the total water of the condensation reaction was removed by distillation as the azeotrope.
- the final temperature was 139°C.
- the reaction mixture was then cooled to 120°C, 87.05 g. of HOEtA was added, and the slurry maintained at 120° for 1 hour. The temperature was then raised to reflux and the water from this final condensation reaction completely removed over a 6 hour period by distillation as the azeotrope. The final temperature was 140°C.
- the product was worked up as the free amine as described in Example 1 for free amine work-up procedure. 230 g. of product was obtained which passed through a 100 mesh screen unground; 17 g. of product was retained on the screen.
- Example 3 The same amounts of amines and other raw materials of Example 3 were used. The procedure was identical through the aggregation step. After cooling the aggregated slurry to 125°C., 7.66 g. of DMAPA was added and the slurry was held at 120-125°C. for one hour. Then 10.89 g. MIBPA was added and the slurry was again held at 120-125°C. for one hour. From this point on the procedure was exactly the same as described in Example 3. The final product was worked-up as the free amine form.
- Example 4 The identical procedure of Example 4 was repeated except that the final product was worked-up as the hydrochloric acid salt by the procedure described in Example 1. For this purpose only 14 ml. concentrated hydrochloric acid (12N) was used instead of the 112 ml. used in Example 1. After drying, 240 grams of product was obtained.
- Example 3 The procedure of Example 3 was repeated except that water of the condensation reaction was removed by azeotropic distillation after each of the amine reactions and holding times, i.e., after MIBPA, after DMAPA and after HOEtA reaction instead of as in Example 3.
- the product was obtained as the hydrochloride salt in 240 g. yield.
- Example 1 The same equipment and the same initial charge of EMA and xylene was used as in Example 1. Aggregation, as obtained in Example 1, was precluded by one of two methods: (a) heat slurry of EMA at 200 r.p.m. to 90°C and add 10.89 g. MIBPA plus 1.5 ml. water, continue stirring at 90°C. for one hour, raise temperature to reflux (136°C.) and take off total water of reaction in the Dean-Stark trap continued reflux (final temperature 139°C.); or (b) heat slurry of EMA at 200 r.p.m. to 125°C. and add the MIBPA and water and immediately raise to reflux temperature of 136°C.
- the filtered product was worked up as either the free amine or as the hydrochloride salt by procedures described in Example 1. Again, during work-up, filtering times were long (30 minutes to 2 hours) as contrasted to work-up filtering times associated with aggregated products of Examples 1 through 7 where these times varied from 5 to 10 minutes. Finally, non-aggregated products, prepared by this procedure and others to follow, dried poorly and had to be ground or ball-milled prior to sieving through a 100 mesh screen in contrast to aggregated products from Examples 1 through 7 which required no grinding or ball-milling prior to screening through 100 mesh screens after drying.
- This example utilized the same equipment and the same EMA and xylene charge as in Example 8.
- the slurry was heated to 90-95°C. and 10.89 g. (0.075 mole) MIBPA was added and stirred at 95°C. for 1 hour.
- 7.66 g. (0.0075 mole) DMAPA was added and stirred at 95°C. for 1 hour.
- the slurry was heated to reflux (134°C.) and water of reaction was completely removed by azeotropic distillation to a final temperature of 139°C.
- the slurry was then cooled to 95°C. and 87.05 g. of hydroxy- ethylamine was added and the slurry stirred at 95°C. for 1 hour.
- the slurry temperature was then raised to 134°C. and the total water of reaction was completely removed by azeotropic distillation to a final temperature of 139 to 140°C.
- the final slurry was filtered hot (30 minutes) and worked up as the free amine by the procedure of Example 1, dried, ground by extensive ball milling and screened through a 100 mesh screen.
- the recovered yields over 12 runs varied from 219 to 244 grams depending on the ball-milling efficiency prior to screening.
- Example 8 This procedure was the same as Example 8 except that the water of reaction was not removed after addtion of MIBPA but was allowed to remain in the reaction slurry until after the DMAPA addition and then the total water of reaction from both amine reactions was removed in a single final azeotropic distillation. Final slurry temperature was 140°C. The product was worked-up as the free amine.
- Example 2 This procedure was identical to that of Example 1 except that the water of reaction was not removed after addition of MIBPA, following aggregation, but was allowed to remain in the reaction mixture slurry until after the DMAPA addition and then the total water of reaction from both amine reactions was removed in a single final azeotropic distillation. The finaly slurry was filtered hot in less than 5 minutes and the product was worked up as the free amine by the procedure of Example 1.
- Example 8 A series of comparable runs were made using the procedure of Example 1 wherein the aggregation time and stirring speed were varied. The products were all finished as the free amine following the Example 1 procedures. The results are shown in the following table as compared with a non-aggregated product prepared by Example 8.
- a one-liter flask was used and the charge was 700 ml. solvent and 50 g. of EMA.
- a 20 ml. aliquot of the slurry was removed and placed in vials. After cooling, the vials were shaken and the time for settling of the polymer from the solvent was measured with a stop watch as an indication of aggregate development. The results are recorded below.
- a measure of particles size in dispersion, whether aggregated or non-aggregated, is the swelling index defined as the grams of aqueous or other dispersant which is absorbed at equilibrium per gram of polymer derivative.
- a suitable sized sample is dispersed in excess dispersant and adjusted to pH 4 or any other desired pH value. The dispersion is allowed to reach equilibrium over a 1 hour period and is then centrifuged at 750 x g. for thirty minutes in a preweighed centrifuge bottle. The supernate is decanted and the weight of centrifuged swollen gel is determined. All of the values are reported using 0.04 Molar saline as the dispersant and a pH of 4.0. The swelling index number is thus the weight of 0.04M saline absorbed by one gram of polymer.
- Swelling is known to be inversely proportional to the crosslink density for crosslinked insoluble resins. For a series of derivatives with increasing MIBPA, the swelling decreases as expected, all other parameters being equal.
- Protein adsorption capacity was measured by the following method. 40 mg. human albumin and 10 mg. of polymer product in the amine or salt form were dispersed in 1.0 ml. of 0.04 molar saline and the pH adjusted to 7.0. The slurry was shaken for 30 minutes while keeping the pH at 7.0. After the 30 minute adsorption period the resin-albumin complex was centrifuged while saving the supernate. The solids were washed 3 times with 1.0 ml. water (5-min. shaking, centrifuging) and the combined supernates were assayed for protein by the method of Miller-Lowry, Analytical Chemistry, 31, 964 (1959). The albumin capacity values are given in terms of mg. albumin adsorbed per mg. polymer product.
- Example 14 The preparations listed in Example 14 are summarized in the following table wherein their albumin capacity is given as a result of preparation variation.
- Aggregated products of the type described not only have improved filtration characteristics during synthesis processes but have been found to give high flow characteristics during processes of plasma fractionation.
- non-aggregated polymers used for plasma fractionation by adsorbing desired proteins from plasma solutions had to be separated from the mother liquor by centrifugation processes because of immediate clogging of filter papers and cloths.
- the present aggregated products with their improved and stable filtration character, were able to be used in plasma fractionation processes and separated from mother liquors by conventional vacuum filtration processes with fast filter times and little or no filter plugging in the presence of proteinaceous material, thus avoiding the need for expensive centrifugation-type apparatus.
- Flow rates of 0.04 molar saline were measured for both aggregated and non-aggregated polyelectrolyte types.
- the expressed value of "relative flow rate” is given in cubic cm. per hour per unit volume of resin bed in the column under gravity flow and maintaining a 20 cm. saline head on top of the resin during the test.
- the DMAPA used in several of the previous Examples illustrates an example of a dialkylaminoalkylimide substituent on the polyelectrolyte.
- Another such substituent was the DEAEA(diethylaminoethylamine) used in Examples 2 and 7 (run 3). These two amines were used to represent aggregated dialkylaminoalkylimide polyelectrolyte substitution with 5 mole percent MIBPA in a 5/90 composition and with 5 mole percent HMDA and 85 mole percent HOEtA in a 5/5/85 composition.
- non-aggregated dialkylaminoalkylimide preparations were made using the Example 9 procedure for the 5/5/85 compositions and the Example 8 procedure for the 5/90 compositions except that in no case was water added with any of the amines.
- the amines used were dimethylaminoethylamine, diethylaminoethylamine, diethylaminopropylamine, dimethylaminopropylamine, di-n-butylaminopropylamine, di-hydroxyethylaminopropylamine and 2 - amino - 5 - diethyl- aminopentane.
- N-phenylethylenediamine was also used to prepare the above non-aggregated resins.
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- External Artificial Organs (AREA)
- Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US05/818,919 US4118554A (en) | 1977-07-25 | 1977-07-25 | Aggregated polyelectrolytes |
US818919 | 1977-07-25 |
Publications (2)
Publication Number | Publication Date |
---|---|
EP0000977A1 EP0000977A1 (en) | 1979-03-07 |
EP0000977B1 true EP0000977B1 (en) | 1981-09-02 |
Family
ID=25226753
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP78300175A Expired EP0000977B1 (en) | 1977-07-25 | 1978-07-21 | Aggregated polyelectrolytes, their preparation and uses in the fractionation of blood and other proteinaceous substances |
Country Status (15)
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4411795A (en) * | 1980-03-10 | 1983-10-25 | Baxter Travenol Laboratories, Inc. | Particle adsorption |
US6986902B1 (en) | 1998-04-28 | 2006-01-17 | Inex Pharmaceuticals Corporation | Polyanionic polymers which enhance fusogenicity |
WO1999055743A1 (en) * | 1998-04-28 | 1999-11-04 | Inex Pharmaceuticals Corporation | Polyanionic polymers which enhance fusogenicity |
US6740633B2 (en) * | 2000-05-09 | 2004-05-25 | Basf Aktiengesellschaft | Polyelectrolyte complexes and a method for production thereof |
JP2003535438A (ja) * | 2000-05-09 | 2003-11-25 | ビーエーエスエフ アクチェンゲゼルシャフト | 高分子電解質複合体およびその製造法 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3157595A (en) * | 1959-09-16 | 1964-11-17 | Monsanto Co | Clarification of water with copolymers containing half-amides of olefinic anhydrides |
US3554985A (en) * | 1963-01-02 | 1971-01-12 | Monsanto Co | Cross-linked copolymer polyelectrolytes based on alpha,beta-ethylenically unsaturated acids |
GB1058260A (en) * | 1963-01-02 | 1967-02-08 | Monsanto Co | Removal of surface active agents from water |
US3340680A (en) * | 1966-02-01 | 1967-09-12 | Monsanto Co | Air purification process |
US3655509A (en) * | 1969-05-29 | 1972-04-11 | Monsanto Co | Process for the separation of virus from non-viral proteins |
US3555001A (en) * | 1969-05-29 | 1971-01-12 | Monsanto Co | Process for the fractionation of plasma and serum using water-insoluble polyelectrolytes containing diloweralkylaminoloweralkylimide groups |
US3651213A (en) * | 1969-05-29 | 1972-03-21 | Monsanto Co | Method for the immunization of a living animal body against viral disease |
-
1977
- 1977-07-25 US US05/818,919 patent/US4118554A/en not_active Expired - Lifetime
-
1978
- 1978-07-21 JP JP8930778A patent/JPS5460392A/ja active Granted
- 1978-07-21 HU HU78MO1020A patent/HU180881B/hu not_active IP Right Cessation
- 1978-07-21 DE DE7878300175T patent/DE2861005D1/de not_active Expired
- 1978-07-21 BR BR7804723A patent/BR7804723A/pt unknown
- 1978-07-21 RO RO94745A patent/RO85538B/ro unknown
- 1978-07-21 PT PT68335A patent/PT68335B/pt unknown
- 1978-07-21 AU AU38241/78A patent/AU520096B2/en not_active Expired
- 1978-07-21 EP EP78300175A patent/EP0000977B1/en not_active Expired
- 1978-07-21 ES ES471955A patent/ES471955A1/es not_active Expired
- 1978-07-21 IT IT26004/78A patent/IT1097313B/it active
- 1978-07-21 AT AT0531878A patent/AT365612B/de not_active IP Right Cessation
- 1978-07-21 SU SU782641107A patent/SU795490A3/ru active
- 1978-07-21 IL IL55193A patent/IL55193A/xx unknown
- 1978-07-24 CA CA308,001A patent/CA1129145A/en not_active Expired
Also Published As
Publication number | Publication date |
---|---|
ATA531878A (de) | 1981-06-15 |
IL55193A (en) | 1981-06-29 |
PT68335A (en) | 1978-08-01 |
US4118554A (en) | 1978-10-03 |
AU3824178A (en) | 1980-01-24 |
JPS6330325B2 (enrdf_load_stackoverflow) | 1988-06-17 |
EP0000977A1 (en) | 1979-03-07 |
RO85538B (ro) | 1984-11-30 |
IT7826004A0 (it) | 1978-07-21 |
PT68335B (pt) | 1994-02-25 |
HU180881B (en) | 1983-05-30 |
JPS5460392A (en) | 1979-05-15 |
DE2861005D1 (en) | 1981-11-26 |
IT1097313B (it) | 1985-08-31 |
RO85538A (ro) | 1984-10-31 |
BR7804723A (pt) | 1979-04-03 |
CA1129145A (en) | 1982-08-03 |
AT365612B (de) | 1982-02-10 |
SU795490A3 (ru) | 1981-01-07 |
AU520096B2 (en) | 1982-01-14 |
IL55193A0 (en) | 1978-09-29 |
ES471955A1 (es) | 1979-10-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA1338730C (en) | Process for the agglomeration of water swellable polymers by means of melting granulation or sinter granulation with powder like agents and the use of the granular material | |
KR100286528B1 (ko) | 교차 결합된 메타크릴산 무수물 공중합체들 | |
US3998907A (en) | Rubber-modified dicarboxylic acid imide copolymers | |
EP0000650B1 (en) | Non-activating polyelectrolytes and their use in a method for separation of blood coagulation factors | |
US3332841A (en) | Method of treating hyperacidity | |
EP0023322A1 (en) | Use of a crosslinked polyvinyl pyrrolidone gel as a gel chromatography material | |
GB1571182A (en) | Carrier-bound biologically active substances and process for their manufacture | |
EP0000977B1 (en) | Aggregated polyelectrolytes, their preparation and uses in the fractionation of blood and other proteinaceous substances | |
US4211664A (en) | Process for making composite magnetic material | |
US4139499A (en) | Thermally reversible amphoteric ion exchange resins of improved demineralization capacity | |
JPS5956411A (ja) | エチレンとアルファ−オレフィンとの共重合体の製造方法 | |
US4238569A (en) | Preparation of hydrophilic material for gel chromatography | |
US3655509A (en) | Process for the separation of virus from non-viral proteins | |
EP0137258A2 (en) | Zirconia-titania-silica tergels and their use as catalyst supports | |
CA2098658A1 (en) | Porous pyrolyzed polyacrylonitrile | |
EP0728152B1 (en) | Removal of base residues from poly(vinyl alcohol) reaction-slurries | |
JPH04317740A (ja) | 液体クロマトグラフィー用充填剤 | |
EP0421525B1 (en) | Process for the preparation of ethylene-propylene copolymers | |
AU596509B2 (en) | Improved insoluble vinyl lactam clarifiers | |
US3846543A (en) | Process for the separation of virus from non-viral proteins | |
US3424588A (en) | Chillproofing fermented beverages with polyvinyl resin modified clays | |
JPH03152108A (ja) | 微粒子状スチレン―ジビニルベンゼン共重合体の合成法および液体クロマトグラフィー用充填剤の製造法 | |
US4758633A (en) | Insoluble vinyl lactam clarifiers | |
KR100302953B1 (ko) | 교차 결합된 메타크릴산 무수물 공중합체들을 이용한단백질 흡착방법 | |
JPS5829135B2 (ja) | 蛋白質に吸着された有機化合物の分離方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
AK | Designated contracting states |
Designated state(s): BE CH DE FR GB NL SE |
|
17P | Request for examination filed | ||
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
AK | Designated contracting states |
Designated state(s): BE CH DE FR GB NL SE |
|
REF | Corresponds to: |
Ref document number: 2861005 Country of ref document: DE Date of ref document: 19811126 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: SE Payment date: 19920617 Year of fee payment: 15 Ref country code: GB Payment date: 19920617 Year of fee payment: 15 Ref country code: DE Payment date: 19920617 Year of fee payment: 15 Ref country code: CH Payment date: 19920617 Year of fee payment: 15 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: BE Payment date: 19920623 Year of fee payment: 15 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: FR Payment date: 19920728 Year of fee payment: 15 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: NL Payment date: 19920731 Year of fee payment: 15 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GB Effective date: 19930721 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SE Effective date: 19930722 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CH Effective date: 19930731 Ref country code: BE Effective date: 19930731 |
|
BERE | Be: lapsed |
Owner name: MONSANTO CY Effective date: 19930731 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: NL Effective date: 19940201 |
|
NLV4 | Nl: lapsed or anulled due to non-payment of the annual fee | ||
GBPC | Gb: european patent ceased through non-payment of renewal fee |
Effective date: 19930721 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: FR Effective date: 19940331 |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: DE Effective date: 19940401 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: ST |
|
EUG | Se: european patent has lapsed |
Ref document number: 78300175.3 Effective date: 19940210 |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |